Brad Sorensen's questions to Ensysce Biosciences (ENSC) leadership • Q4 2023
Question
Inquired about other potential partnership opportunities beyond the one mentioned in Europe and asked for any developments on securing additional government funding.
Answer
D. Kirkpatrick responded that they are continuing discussions with OncoZenge and are also exploring opportunities for their more developed opioid products with other groups. The company is also actively exploring additional funding opportunities through the NIH HEAL program.